Precision BioSciences gets FDA orphan drug designations for DMD treatment
Go back to Precision BioSciences gets FDA orphan drug designations for DMD treatment| (NASDAQ: DTIL) | Delayed: 8.85 +0.13 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.72 | 52 Week High | $ | |||
| Open | $8.81 | 52 Week Low | $ | |||
| Day High | $9.08 | P/E | N/A | |||
| Day Low | $8.63 | EPS | $ | |||
| Volume | 305,181 | |||||

